псилоцибин脉冲疗法减少了随机对照试验的盲目延长阶段的集群头痛发作频率
Emmanuelle A D Schindler1, R Andrew Sewell2, Christopher H Gottschalk3
1Department of Neurology, Yale School of Medicine, New Haven, CT, United States of America; Neurology Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America; Headache Center of Excellence, Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America.
Journal of the neurological sciences
|April 6, 2024
概括
重复治疗psilocybin显著减少了集群头痛的发作. 这种迷幻疗法对集群头痛患者有希望,先前的反应不会影响结果.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 一项先前的研究表明,在脉冲注射西宾后,集群头痛发作频率没有显著减少.
- 进行了盲目延长阶段,以评估重复西治疗方案的安全性和有效性.
研究的目的:
- 评估重复施用 псилоцибин脉冲治疗集群头痛的安全性和有效性.
- 为了确定前期对西的反应是否预测了重复治疗的结果.
主要方法:
- 最初研究的10名参与者完成了延长阶段,在第一轮研究后至少六个月接受了psilocybin脉冲.
- 头痛日记在初始药物治疗前两周和初始药物治疗后八周保持.
- 所有十名参与者都被纳入最终分析.
主要成果:
- 在psilocybin脉冲后的三周内,观察到集群攻击频率的显著减少 (从18.4到9.8次攻击/周,p=0.013).
- 发作频率减少了大约50%,不管第一轮的个体反应如何.
- 西被很好地容忍,没有报告严重或意想不到的不良事件.
结论:
- 重复使用psilocybin脉冲疗法显著降低了集群头痛发作频率.
- 以前对西的个人反应可能不是重复治疗的有效性的预测指标.
- 需要对更大,更多样化的样本和更长的随访进行进一步的研究,以确定psilocybin在集群头痛中的治疗潜力.
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.